Short communication: SAHA (Vorinostat) induces CDK9 Thr-186 (T-Loop) phosphorylation in resting CD4+ T cells: Implications for reactivation of latent HIV

AIDS Research and Human Retroviruses

Volumn 31, Issue 1, 2015, Pages 137-141

  Ramakrishnan, Rajesh ^a   Liu, Hongbing ^a   Rice, Andrew P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN T1; DISULFIRAM; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; VORINOSTAT; ALDEHYDE DEHYDROGENASE INHIBITOR; CCNT1 PROTEIN, HUMAN; CDK9 PROTEIN, HUMAN; CYCLIN T; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DONOR; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JURKAT CELL LINE; LATENT PERIOD; LATENT VIRUS INFECTION; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS REACTIVATION; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

ACETALDEHYDE DEHYDROGENASE INHIBITORS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYCLIN T; CYCLIN-DEPENDENT KINASE 9; DISULFIRAM; HISTONE DEACETYLASE INHIBITORS; HIV INFECTIONS; HIV-1; HUMANS; HYDROXAMIC ACIDS; JURKAT CELLS; PHOSPHORYLATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84937145868     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0288     Document Type: Article

References (23)

1. Karn J and Stoltzfus CM: Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb Perspect Med 2012;2:a006916
2. Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, and Jones KA: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998;12:3512-3527
3. Budhiraja S, Famiglietti M, Bosque A, Planelles V, and Rice AP: Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4 + T cells. J Virol 2013;87: 1211-1220
4. Chiang K, Sung TL, and Rice AP: Regulation of cyclin T1 and HIV-1 replication by microRNAs in resting CD4 +T lymphocytes. J Virol 2012;86:3244-3252
5. Dong C, Kwas C, and Wu L: Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 2009;83:3518-3527
6. Ramakrishnan R, Dow EC, and Rice AP: Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4( + ) T lymphocytes. J Leukoc Biol 2009;86:1345-1350
7. Dow EC, Liu H, and Rice AP: T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. J Cell Physiol 2010;224:84-93
8. Ott M, Geyer M, and Zhou Q: The control of HIV transcription: Keeping RNA polymerase II on track. Cell Host Microbe 2011;10:426-435
9. Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, and Margolis DM: Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 2009;25:207-212
10. Contreras X, Schweneker M, Chen CS, McCune JM, Deeks SG, Martin J, and Peterlin BM: Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem 2009;284:6782-6789
11. Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, et al.: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 2012;487:482-485
12. Van Lint C, Bouchat S, and Marcello A: HIV-1 transcription and latency: An update. Retrovirology 2013;10:67
13. Budhiraja S, Ramakrishnan R, and Rice AP: Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4T + T cells and inhibits HIV-1 gene expression. Retrovirology 2012;9:52
14. Larochelle S, Amat R, Glover-Cutter K, Sanso M, Zhang C, Allen JJ, Shokat KM, Bentley DL, and Fisher RP: Cyclindependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat Struct Mol Biol 2012; 19:1108-1115
15. Banerjee C, Archin N, Michaels D, Belkina AC, Denis GV, Bradner J, Sebastiani P, Margolis DM, and Montano M: BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol 2012;92:1147-1154
16. Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L, Aull K, Li PC, Planelles V, Bradner JE, et al.: BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle 2013;12:452-462
17. Li Z, Guo J, Wu Y, and Zhou Q: The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res 2013;41:277-287
18. Zhu J, Gaiha GD, John SP, Pertel T, Chin CR, Gao G, Qu H, Walker BD, Elledge SJ, and Brass AL: Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep 2012;2:807-816
19. Faiman MD, Jensen JC, and Lacoursiere RB: Elimination kinetics of disulfiram in alcoholics after single and repeated doses. Clin Pharmacol Ther 1984;36:520-526
20. McCance-Katz EF, Kosten TR, and Jatlow P: Disulfiram effects on acute cocaine administration. Drug Alcohol Depend 1998;52:27-39
21. Xing S, Bullen CK, Shroff NS, Shan L, Yang HC, Manucci JL, Bhat S, Zhang H, Margolick JB, Quinn TC, et al.: Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4 + T cell model without inducing global T cell activation. J Virol 2011;85:6060-6064
22. Pearson R, Kim YK, Hokello J, Lassen K, Friedman J, Tyagi M, and Karn J: Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 2008;82:12291-12303
23. Abramoff MD, Magelhaes PJ, and Ram SJ: Image processing with ImageJ. Biophotonics Int 2004;11:36-42